HIV seroconversions in the PrEP impact trial

被引：0
|
作者：
Cartier, A. [1 ]
Milinkovic, A. [1 ]
Pereira, B. [1 ]
Reeves, I. [2 ]
Ogaz, D. [3 ]
Mitchell, H. [3 ]
Saunders, J. [3 ,4 ]
Charlett, A. [3 ]
Chiavenna, C. [3 ]
Sullivan, A.
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Homerton Healthcare NHS Fdn Trust, London, England
[3] UK Hlth Secur Agcy, London, England
[4] Cent & North West London NHS Fdn Trust, London, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
432
引用
收藏
页码：498 / 499
页数：2
相关论文
共 50 条
  • [31] The PrEP Impact trial - experience in setting up independent provider sites
    Cartier, Andrea
    Jaffer, Sajjida
    Diamente, Victor
    Foster, Damon
    Golombek, Rainer
    Chhibbar, Pallavi
    Estcourt, Claudia
    Sabin, Caroline
    Rodger, Alison
    Sullivan, Ann
    HIV MEDICINE, 2021, 22 : 99 - 99
  • [32] PrEP stigma affects PrEP uptake: attitudes towards pre-exposure prophylaxis (PrEP) amongst HIV vaccine trial participants in Soweto, South Africa
    Laher, F.
    Salami, T.
    Hornschuh, S.
    Makhale, L. M.
    Khunwane, M.
    Andrasik, M.
    Gray, G. E.
    Tieu, H. -V.
    Dietrich, J. J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [33] Study protocol for an efficacy trial of the “PrEP for Health” intervention to increase HIV PrEP use among people who inject drugs
    Angela R. Bazzi
    Michelle Bordeu
    Katrina Baumgartner
    Darien M. Sproesser
    Christopher M. Bositis
    Douglas S. Krakower
    Matthew J. Mimiaga
    Katie B. Biello
    BMC Public Health, 23
  • [34] Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs
    Bazzi, Angela R.
    Bordeu, Michelle
    Baumgartner, Katrina
    Sproesser, Darien M.
    Bositis, Christopher M.
    Krakower, Douglas S.
    Mimiaga, Matthew J.
    Biello, Katie B.
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [35] The potential impact of PrEP (pre-exposure prophylaxis) in a single HIV centre
    Cavilla, S.
    HIV MEDICINE, 2016, 17 : 31 - 31
  • [36] Impact of a clinical pharmacist within an HIV PrEP program for patients experiencing homelessness
    McElyea, Julia
    Bistransin, Katie
    Bana, Shrina
    Alvarez, Kristin S.
    Brown, Larry Steven
    Persaud, Donna
    King, Helen
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (01) : 324 - 329
  • [37] Impact of an HIV pre-exposure prophylaxis dashboard on veteran PrEP enrollment
    Kerbler, Mary Kate
    Isaacs, Carrie
    Eatmon, Courtney
    Reid, Jennifer
    Davis, Kelly W.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (02) : 471 - 475
  • [38] PrEP use in the HVTN 702 HIV vaccine efficacy trial conducted in South Africa
    Odhiambo, J.
    Huang, Y.
    Malahleha, M.
    Laher, F.
    Grunenberg, N.
    Janes, H.
    Moodie, Z.
    Ward, A.
    Kassim, S.
    Mda, P.
    Naicker, N.
    Kalonji, D.
    Nchabeleng, M.
    Lazarus, E.
    Grove, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [39] PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial
    Heffron, Renee
    Muwonge, Timothy R.
    Thomas, Katherine K.
    Nambi, Florence
    Nakabugo, Lylianne
    Kibuuka, Joseph
    Thomas, Dorothy
    Feutz, Erika
    Meisner, Allison
    Ware, Norma C.
    Wyatt, Monique A.
    Simoni, Jane M.
    Katz, Ingrid T.
    Kadama, Herbert
    Baeten, Jared M.
    Mujugira, Andrew
    Partners PrEP Program Team
    ECLINICALMEDICINE, 2022, 52
  • [40] THE EXPLOITATION OF "EXPLOITATION" IN THE TENOFOVIR PREP TRIAL IN CAMEROON: LESSONS LEARNED FROM MEDIA COVERAGE OF AN HIV PREVENTION TRIAL
    Mack, Natasha
    Robinson, Elizabeth T.
    MacQueen, Kathleen M.
    Moffett, Jill
    Johnson, Laura M.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2010, 5 (02) : 3 - 19
12345